Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Physical Therapy and Nusinersen Impact on Spinal Muscular Atrophy Rehabilitative Outcome
Andrada Mirea, Mădălina Cristina Leanca, Gelu Onose, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 6, pp. 179-179
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

The dynamic of changes of pNFH levels in the CSF compared with the motor scales’ scores during three years of nusinersen treatment in children with spinal muscular atrophy types 2 and 3
Mihaela Badina, Corina Sporea, Gabriel Cristian Bejan, et al.
Balneo and PRM Research Journal (2024) Vol. 15, Iss. Vol.15, no.1, pp. 643-643
Open Access | Times Cited: 6
Diving into progress: a review on current therapeutic advancements in spinal muscular atrophy
P. S. Bagga, Sudhakar Singh, Gobind Ram, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 6
Impact of Nusinersen on Neurofilament, Creatinine Levels, and Motor Function in Pediatric Spinal Muscular Atrophy Rehabilitation: A Biomarker Analysis
Mihaela Badina, Corina Sporea, Gabriel Cristian Bejan, et al.
Balneo and PRM Research Journal (2024) Vol. 15, Iss. Vol.15, no. 2, pp. 681-681
Open Access | Times Cited: 5
Motor function and compound muscle action potential amplitude in children with spinal muscular atrophy treated with nusinersen
Yu Peng, Lianying Feng, Jinfeng Wu, et al.
Brain and Development (2025) Vol. 47, Iss. 1, pp. 104316-104316
Closed Access
Pushing the boundaries: future directions in the management of spinal muscular atrophy
Fiona Moultrie, Laura Chiverton, Isabel Hatami, et al.
Trends in Molecular Medicine (2025)
Open Access
Experience of Nusinersen treatment in Advanced Spinal Muscular Atrophy Type 1: Characteristics of Late Responders with Delayed Treatment Efficacy
Sachi Tokunaga, Hideki Shimomura, Takuya Horibe, et al.
European Journal of Paediatric Neurology (2025) Vol. 54, pp. 171-177
Closed Access
A case of spinal muscular atrophy type 0 treated with nusinersen without progression of early-onset scoliosis – possibility of preventing scoliosis with a rehabilitation program focusing on postural management
Tomokazu Kimizu, Saki Yokawa, Takuya Horibe, et al.
Brain and Development (2025) Vol. 47, Iss. 3, pp. 104354-104354
Open Access
Biomarker Evolution in Pediatric SMA: Insights from CSF pNF-H Dynamics and SMN2 Copy Number During Nusinersen Therapy
Mihaela Badina, Gabriel Cristian Bejan, Andrada Mirea, et al.
Balneo and PRM Research Journal (2025) Vol. 16, Iss. Vol 16 No. 1, pp. 777-777
Open Access
Rehabilitation improves the effectiveness of nusinersen in children with type 2 spinal muscular atrophy: pNF-H and muscle MRI as potential biomarkers
Yifan Sun, Wei Li, Xin Cui, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
Clinical and Electrophysiological Changes in Pediatric Spinal Muscular Atrophy after 2 Years of Nusinersen Treatment
Mihaela Axente, Andrada Mirea, Corina Sporea, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2074-2074
Open Access | Times Cited: 16
Considerations for Treatment in Clinical Care of Spinal Muscular Atrophy Patients
Stephanie Voight, Kapil Arya
Children (2024) Vol. 11, Iss. 4, pp. 495-495
Open Access | Times Cited: 3
Non-Invasive Spinal Cord Stimulation for Motor Rehabilitation of Patients with Spinal Muscular Atrophy Treated with Orphan Drugs
Anton Novikov, Maria Maldova, Natalia Shamantseva, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1162-1162
Open Access | Times Cited: 2
Gene-based therapy for the treatment of spinal muscular atrophy types 1 and 2 : a systematic review and meta-analysis
Bunchai Chongmelaxme, Varalee Yodsurang, Ponlawat Vichayachaipat, et al.
Gene Therapy (2024)
Open Access | Times Cited: 1
The socioeconomic burden of spinal muscular atrophy in Saudi Arabia: a cross-sectional pilot study
Khloud Mubark Alotaibi, Mohannad Alsuhaibani, Khalid S. Al-Essa, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Functional and Structural Changes in Patients with Spinal Muscular Atrophy Treated in Poland during 12-Month Follow-Up: A Prospective Cohort Study
Aleksandra Bieniaszewska, Magdalena Sobieska, Ewa Gajewska
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4232-4232
Open Access | Times Cited: 1
Rehabilitation for spinal muscular atrophy patients in China: a national cross-sectional study
Duan Wang, Ting Zhang, Li Yi, et al.
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Physiotherapeutic Interventions for Patients With Rare Genetic Muscle-Wasting Disorders: A Systematic Review and Meta-Analysis
Abdullah Alzahrani
Cureus (2024)
Open Access | Times Cited: 1
Early Intervention services in the era of genomic medicine: setting a research agenda
Katherine E. MacDuffie, Betty Cohn, Paul S. Appelbaum, et al.
Pediatric Research (2024)
Open Access | Times Cited: 1
Predictive Clinical-Biological Markers Over the First 3 Years of Nusinersen Treatment in SMA Type 1 Patients
Mihaela Badina, Andrada Mirea, Corina Sporea, et al.
Balneo and PRM Research Journal (2024) Vol. 15, Iss. Vol.15, no. 4, pp. 754-754
Closed Access | Times Cited: 1
Evolution of Functional and Paraclinical Markers as Predictive Factors in Pediatric Late-Onset SMA Under Nusinersen Treatment: The Role of CSF pNF-H
Mihaela Badina, Gabriel Cristian Bejan, Corina Sporea, et al.
Balneo and PRM Research Journal (2024) Vol. 15, Iss. Vol.15, no. 4, pp. 755-755
Closed Access | Times Cited: 1
Parent Reports of Developmental Service Utilization After Newborn Screening
Elizabeth Reynolds, Sarah Nelson Potter, Samantha Scott, et al.
International Journal of Neonatal Screening (2024) Vol. 11, Iss. 1, pp. 3-3
Open Access | Times Cited: 1
Rehabilitation in Spinal Muscular Atrophy; A Narrative Review
Seth Kwame Agyenkwa, Pınar Cibooğlu, Nour Jhar, et al.
European Journal of Therapeutics (2023) Vol. 29, Iss. 3, pp. 656-666
Open Access | Times Cited: 3
State Coordinator Perceptions of Linkages Between Newborn Screening and Early Intervention
Elizabeth Reynolds, Sara M. Andrews, Sheresa Blanchard, et al.
Journal of Early Intervention (2023) Vol. 47, Iss. 1, pp. 46-62
Closed Access | Times Cited: 2
Exploring the Application and Usability of Emerging Technologies in Neuromotor Rehabilitation for a Patient with 5Q-Spinal Muscular Atrophy Type 2 Receiving a Gene-Based Therapy: A Single Case Study
Giulia Barraco, Luigi Macchitella, Giuseppe Accogli, et al.
Lecture notes in computer science (2024), pp. 50-57
Closed Access
Rehabilitation in children with spinal muscular atrophy
O. Yu. Katikova
Реабилитология. (2024) Vol. 2, Iss. 2, pp. 227-246
Closed Access
Page 1 - Next Page

Scroll to top